Suppr超能文献

获得性免疫缺陷综合征及艾滋病相关综合征患者的金黄色葡萄球菌菌血症和复发性葡萄球菌感染。

Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex.

作者信息

Jacobson M A, Gellermann H, Chambers H

机构信息

Department of Medicine, University of California, San Francisco.

出版信息

Am J Med. 1988 Aug;85(2):172-6. doi: 10.1016/s0002-9343(88)80337-1.

Abstract

PURPOSE

An increased incidence of Staphylococcus aureus bacteremia has recently been described in patients with the acquired immunodeficiency syndrome (AIDS). However, other risk factors for community-acquired S. aureus bacteremia (including intravenous drug abuse and lymphedema) were present in nearly all these AIDS-related cases of S. aureus infection. Our purpose was to review cases of S. aureus bacteremia that occurred in patients with AIDS or AIDS-related complex (ARC) who did not have a recent history of intravenous drug use, lymphatic obstruction, or neutropenia.

PATIENTS AND METHODS

Patients at San Francisco General Hospital between October 1984 and October 1987 with blood culture results positive for S. aureus were identified. A review of this group revealed 22 cases of S. aureus bacteremia that occurred in 18 patients with an underlying diagnosis of AIDS or ARC, none of whom had a recent history of intravenous drug use, lymphedema secondary to Kaposi's sarcoma, or neutropenia.

RESULTS

An intravenous catheter was the single most important risk factor for S. aureus bacteremia and was identified as the source for bacteremia in 16 (73 percent) of the 22 episodes. Based on 1986 outpatient clinic records, we calculated an incidence of S. aureus bacteremia occurring in non-intravenous-drug-using male AIDS or ARC patients, 18 to 44 years old, that was 5.4 episodes/1,000 patients. Although the mean duration of appropriate antibiotic therapy was 18 days, late metastatic complications of S. aureus bacteremia occurred in six (35 percent) of 17 AIDS/ARC patients who survived initial antibiotic therapy.

CONCLUSION

Non-intravenous-drug-using AIDS and ARC patients (especially those with indwelling venous catheters) appear to be at high risk for S. aureus bacteremia, with a higher late metastatic complication rate than that reported for recent historical control subjects.

摘要

目的

最近有报道称,获得性免疫缺陷综合征(AIDS)患者金黄色葡萄球菌菌血症的发病率有所增加。然而,几乎所有这些与AIDS相关的金黄色葡萄球菌感染病例都存在社区获得性金黄色葡萄球菌菌血症的其他危险因素(包括静脉药物滥用和淋巴水肿)。我们的目的是回顾那些没有近期静脉药物使用史、淋巴阻塞或中性粒细胞减少症的AIDS或AIDS相关综合征(ARC)患者发生金黄色葡萄球菌菌血症的病例。

患者与方法

确定了1984年10月至1987年10月期间旧金山综合医院血培养结果为金黄色葡萄球菌阳性的患者。对该组患者的回顾显示,18例潜在诊断为AIDS或ARC的患者发生了22例金黄色葡萄球菌菌血症,这些患者均无近期静脉药物使用史、卡波西肉瘤继发的淋巴水肿或中性粒细胞减少症。

结果

静脉导管是金黄色葡萄球菌菌血症最重要的单一危险因素,在22次发作中有16次(73%)被确定为菌血症的来源。根据1986年门诊记录,我们计算出18至44岁、非静脉药物使用的男性AIDS或ARC患者中金黄色葡萄球菌菌血症的发病率为5.4次/1000例患者。尽管适当抗生素治疗的平均持续时间为18天,但在17例经初始抗生素治疗存活的AIDS/ARC患者中,有6例(35%)发生了金黄色葡萄球菌菌血症的晚期转移性并发症。

结论

非静脉药物使用的AIDS和ARC患者(尤其是那些有留置静脉导管的患者)似乎有发生金黄色葡萄球菌菌血症的高风险,其晚期转移性并发症发生率高于近期历史对照研究对象报道的发生率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验